Indication

Multi-antibiotic Resistance

1 clinical trial

1 product

Clinical trial

Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies From B Lymphocytes of Patients Who Have Been Followed for Infection or Colonization With Pseudomonas Aeruginosa: a Prospective Monocentric Trial

Status: Recruiting, Estimated PCD: 2025-10-01

Product

Isolation of anti-Pseudomonas antibodies